A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.

NCT00042718 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
659
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators